Aging Beautifully Part 3: Dementia

449 views
382 views

Published on

Published in: Health & Medicine, Sports
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
449
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
11
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Today I will discuss Urinary Incontinence, the 2nd part of the Aging beautifully series.
  • Reversible cause of mental status change: alcohol abuse, thyroid dysfunction, dehydration and electrolyte disturbance, infection, vit b12 deficiency, medications: anticholinergics (for overactive bladder, tiotropium for asthma
  • IADLS (laundry, housekeeping, managing meds, may get lost in familiar places)
  • AP can enhancetherapietic
  • AP can enhancetherapietic
  • AP can enhancetherapietic
  • AP can enhancetherapietic
  • Pharmacists, we have a role to play… As patient advocates and front-line health care professionals we can educate, recommend better treatment alternatives, ensure their safety, and listen… so someday, our patients can say…
  • Aging Beautifully Part 3: Dementia

    1. 1. You have 9 seconds left…Let’s Play!
    2. 2. Which color is missing??
    3. 3. Guess who’s who?Let’s Play!
    4. 4. Impressive!Scoreboard:• Dr. A• Dr. G• Dr. S• Dr. T
    5. 5. By the way,what istoday’s date?
    6. 6. Memory ispowerful.but not untilwe lose it thatwe fully realizeits significance
    7. 7. AgingBeautifully:Visions & RealitiesPart III: Dementiahttp://www.goodlifeguide.net/wp-content/uploads/2012/09/beach-seniors-X-license.jpgBy Christine HortillosaPharm.D. 2013 CandidateUniversity of Texas at Austin College of Pharmacy5. 9. 2013
    8. 8. DeliriumDementiaAcuteTwo of the following:•Misinterpretation, illusions, hallucinations•Incoherent speech•Disturbance in sleep-wake cycle•Change in psychomotor activityRelated to medical illness + medicationsReversibleProgressiveMarked by memory impairmentNot a normal part of agingIrreversible
    9. 9. Most common formof dementia is…Alzheimer’sdisease
    10. 10. mildmoderatesevere20-24Short-term memory loss;word-finding problemsLoss of IADLs10-19Disorientation to time, place,inability to engage in activitiesNeeds assistance with ADLs<10Loss of speech andambulation, incontinence of boweland bladderDependency in basic ADLs; often requiresaround-the-clock care*ADLS= activities of daily living (bathing, dressing); IADLS=instrumental activities of daily living (housekeeping); MMSE=Mini-Mental Status ExaminationMMSE Examples of cognitive lossExamples of functional lossStages
    11. 11. Drugs for Treatmentof Alzheimer’sDonepezilRivastigmineGalantamineMemantine
    12. 12. DonepezilStarting Dose 5 mg/day; No dose change for renalimpairmentMaintenance Dose 10mg/dayMay also increase to 23mg/dayProperties Cholinesterase inh; partly metabolizedby CYP 2D6 and 3A4Indication For all stages of Alzheimer’sAdverse Effects Bradycardia, syncope, weight loss,N/V/D, InsomniaDDI Anticholinergics, Antipsychotics, Beta-blockers, AlcoholAdministration At bedtime without regard to food
    13. 13. Starting Dose 1.5mg BID; No dosage change forrenal impairmentMaintenance Dose 3-6mg BIDProperties Cholinesterase inhIndication For mild to moderate Alzheimer’s andmild-to moderate dementia withParkinson’sAdverse Effects Has most intense cholinergic (N/V/D)ADE, bradycardia, syncope, dizziness,EPSDDI Anticholinergics, Antipsychotics, Beta-blockers, AlcoholAdministration With meals; for patch (avoid applicationto same spot for 14 days)Rivastigmine
    14. 14. Starting Dose 4 mg BID; Use not reco’d for CrCl<9ml/minMaintenance Dose 8-12mg BID or 8-24mg ER QdayProperties Cholinesterase inh and nicotinereceptor modulator; partly metabolizedby CYP 2D6 and 3A4Indication For mild-to-moderate Alzheimer’sAdverse Effects Bradycardia, syncope, weight loss,N/V/DDDI Anticholinergics, Antipsychotics, Beta-blockers, AlcoholAdministration With meals; if therapy is interrupted for3+ days, restart at lower dose andincrease to current doseGalantamine
    15. 15. MemantineStarting Dose 5 mg/day (max dose of 20mg for CrCl30-49 and max dose 5mg for CrCl 5-29)Maintenance Dose 10mg BIDProperties Blocks glutamate transmissionIndication For moderate to severe Alzheimers;may be used in combination withdonepezilAdverse Effects Hypertension, confusionDDI Sodium bicarbonate, TrimethoprimAdministration Without regard to food
    16. 16. Start with cholinesterase inhibitorsCaution: statistically significant difference ≠ clinical meaningful improvementhttp://inc1979.com/wp-content/uploads/2012/03/tumblr_ljtm2uPiD11qf0uwco1_1280.jpg
    17. 17. How long shouldthe therapy be?• Evaluation at 3-6 months for prevention ofdecline or improvement• Conflicting evidence in unresponsive patients• Taper upon discontinuationhttp://2.bp.blogspot.com/-elpJbUEX820/Trvvb6PtfII/AAAAAAAAB1A/-fPVe_yW-4U/s1600/long+winding+road+p92b_saint_gothard_pass_switzerland.jpg
    18. 18. http://www.toledoblade.com/image/2012/01/22/800x_b1_cCM_z_cT/pharmacist-bryan-01-23-2012.jpgPharmacists arecritical ineffectivealzheimer’sdiseasemanagement.
    19. 19. With your help,I can preservemy memories alittle bit longer.http://1dentalhealthblog.files.wordpress.com/2010/07/elderly-woman.jpg
    20. 20. Discussion.

    ×